Findings seen in adolescents and young adults with T2DM regardless of body weight
TUESDAY, Aug. 25, 2020 (HealthDay News) — Type 2 diabetes may negatively impact bone density around the age of peak bone mass, according to a study published online Aug. 10 in Diabetes Care.
Joseph M. Kindler, from the Children’s Hospital of Philadelphia, and colleagues compared bone health in youth with type 2 diabetes to control patients with obesity or healthy weight. The analysis included youth (56 percent African American; 67 percent female) ages 10 to 23 years with type 2 diabetes (180 patients), obesity (body mass index [BMI] >95th; 226 patients), or healthy weight (BMI <85th; 238 patients).
The researchers observed age-dependent differences in areal bone mineral density (aBMD) and lean BMI z scores between the three groups. In children, aBMD and lean BMI z scores were greater in the type 2 diabetes group versus the obese group, while among adolescents and young adults, aBMD and lean BMI z scores were lower in the type 2 diabetes group versus the obese group. aBMD was approximately 0.5 standard deviations lower for a given lean BMI z score in the type 2 diabetes group and the obese group versus healthy-weight control patients. aBMD also was lower in those with greater visceral fat.
“Results from this study suggest that type 2 diabetes in youth may have a detrimental effect on bone accrual during the critical window of peak bone mass attainment irrespective of obesity status,” the authors write.
Abstract/Full Text (subscription or payment may be required)
EHR-Enabled QI Intervention Improves Chlamydia, Gonorrhea Screening in Teens
Study Looks at Approaches to Prescribing Obesity Medications for Older Adults
Research Challenges Fusion for Lumbar Degenerative Spondylolisthesis
Weight-Loss Surgery Produces Lasting Diabetes Remission
Bariatric Surgery Is Effective Rescue Strategy After GLP-1 Receptor Agonist Failure
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors